Weighing the Benefits and Risks of Proliferating Observational Treatment Assessments Observational Cacophony, Randomized Harmony

被引：31

作者：

Califf, Robert M. ^{[1
]}

Hernandez, Adrian F. ^{[2
,3
]}

Landray, Martin ^{[4
]}

机构：

[1] Verily Life Sci Alphabet, San Francisco, CA USA

[2] Duke Clin Res Inst, Durham, NC USA

[3] Duke Univ, Sch Med, Dept Med, Div Cardiol, Durham, NC 27706 USA

[4] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2020年 / 324卷 / 07期

基金：

英国医学研究理事会;

关键词：

D O I：

10.1001/jama.2020.13319

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This Viewpoint discusses the role of observational study designs and data in the rapid stand-up of an evidence base for managing the COVID-19 pandemic, proposing ways to position observational research as a foundation for rapid follow-on randomized evaluation without premature overinterpretation of its findings.

引用

页码：625 / 626

页数：2

共 10 条

[1] The Magic of Randomization versus the Myth of Real-World Evidence [J].

Collins, Rory ;

Bowman, Louise ;

Landray, Martin ;

Peto, Richard .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (07) :674-678

[2] Real-World Evidence and Real-World Data for Evaluating Drug Safety and Effectiveness [J].

Corrigan-Curay, Jacqueline ;

Sacks, Leonard ;

Woodcock, Janet .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (09) :867-868

[3]

Halpern SD, 2020, JAMA

[4]

Horby P., 2020, N Engl J Med, V17, DOI [10.1056/NEJMoa2021436, DOI 10.1056/NEJMOA2021436]

[5] Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients [J].

Joyner, Michael J. ;

Bruno, Katelyn A. ;

Klassen, Stephen A. ;

Kunze, Katie L. ;

Johnson, Patrick W. ;

Lesser, Elizabeth R. ;

Wiggins, Chad C. ;

Senefeld, Jonathon W. ;

Klompas, Allan M. ;

Hodge, David O. ;

Shepherd, John R. A. ;

Rea, Robert F. ;

Whelan, Emily R. ;

Clayburn, Andrew J. ;

Spiegel, Matthew R. ;

Baker, Sarah E. ;

Larson, Kathryn F. ;

Ripoll, Juan G. ;

Andersen, Kylie J. ;

Buras, Matthew R. ;

Vogt, Matthew N. P. ;

Herasevich, Vitaly ;

Dennis, Joshua J. ;

Regimbal, Riley J. ;

Bauer, Philippe R. ;

Blair, Janis E. ;

van Buskirk, Camille M. ;

Winters, Jeffrey L. ;

Stubbs, James R. ;

van Helmond, Noud ;

Butterfield, Brian P. ;

Sexton, Matthew A. ;

Soto, Juan C. Diaz ;

Paneth, Nigel S. ;

Verdun, Nicole C. ;

Marks, Peter ;

Casadevall, Arturo ;

Fairweather, DeLisa ;

Carter, Rickey E. ;

Wright, R. Scott .

MAYO CLINIC PROCEEDINGS, 2020, 95 (09) :1888-1897

[6] Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics [J].

Kalil, Andre C. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (19) :1897-1898

[7] Against pandemic research exceptionalism [J].

London, Alex John ;

Kimmelman, Jonathan .

SCIENCE, 2020, 368 (6490) :476-477

[8]

Mehra MR, 2020, LANCET, V395, P1820, DOI [10.1016/S0140-6736(20)31324-6, 10.1016/S0140-6736(20)31180-6]

[9]

Petal Horby, 2020, MEDRXIV, DOI [10.1101/2020.07.15.20151852, DOI 10.1101/2020.07.15.201518522020]

[10]

WHO, 2020, Q&A: Hydroxychloroquine and COVID-19

← 1 →